Trial Outcomes & Findings for Trial Comparing Cosmetic Outcomes of Pediatric Laceration Closure Using Skin Glue, Medical Tape Versus Stitches (NCT NCT03280628)

NCT ID: NCT03280628

Last Updated: 2023-07-17

Results Overview

Two blinded Plastic Surgeons will rate the cosmetic outcome of the laceration using a 0 to 100 mm Visual Analogue Scale with a score of 0 corresponding to "worst scar" and a score of 100 corresponding to "best scar"

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

55 participants

Primary outcome timeframe

3 months

Results posted on

2023-07-17

Participant Flow

Participant milestones

Participant milestones
Measure
Absorbable Sutures
Patients will have their laceration closed with sutures that absorb on their own and do not need to be removed. Absorbable Sutures: The patient's doctor will close the patient's laceration with absorbable sutures.
Steri-Strips
Patients will have their laceration closed with a special medical tape called "Steri-Strips." Steri-Strips: The patient's doctor will close the patient's laceration with Steri-Strips.
Dermabond
Patients will have their laceration closed with a special skin glue called "Dermabond" Dermabond: The patient's doctor will close the patient's laceration with Dermabond.
Overall Study
STARTED
20
17
18
Overall Study
COMPLETED
12
11
7
Overall Study
NOT COMPLETED
8
6
11

Reasons for withdrawal

Reasons for withdrawal
Measure
Absorbable Sutures
Patients will have their laceration closed with sutures that absorb on their own and do not need to be removed. Absorbable Sutures: The patient's doctor will close the patient's laceration with absorbable sutures.
Steri-Strips
Patients will have their laceration closed with a special medical tape called "Steri-Strips." Steri-Strips: The patient's doctor will close the patient's laceration with Steri-Strips.
Dermabond
Patients will have their laceration closed with a special skin glue called "Dermabond" Dermabond: The patient's doctor will close the patient's laceration with Dermabond.
Overall Study
Lost to Follow-up
8
6
11

Baseline Characteristics

Trial Comparing Cosmetic Outcomes of Pediatric Laceration Closure Using Skin Glue, Medical Tape Versus Stitches

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Absorbable Sutures
n=20 Participants
Patients will have their laceration closed with sutures that absorb on their own and do not need to be removed. Absorbable Sutures: The patient's doctor will close the patient's laceration with absorbable sutures.
Steri-Strips
n=17 Participants
Patients will have their laceration closed with a special medical tape called "Steri-Strips." Steri-Strips: The patient's doctor will close the patient's laceration with Steri-Strips.
Dermabond
n=18 Participants
Patients will have their laceration closed with a special skin glue called "Dermabond" Dermabond: The patient's doctor will close the patient's laceration with Dermabond.
Total
n=55 Participants
Total of all reporting groups
Age, Continuous
3.50 years
n=5 Participants
3.00 years
n=7 Participants
4.00 years
n=5 Participants
3.00 years
n=4 Participants
Sex: Female, Male
Female
3 Participants
n=5 Participants
5 Participants
n=7 Participants
4 Participants
n=5 Participants
12 Participants
n=4 Participants
Sex: Female, Male
Male
17 Participants
n=5 Participants
12 Participants
n=7 Participants
14 Participants
n=5 Participants
43 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
3 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
18 Participants
n=5 Participants
16 Participants
n=7 Participants
16 Participants
n=5 Participants
50 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
2 Participants
n=4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Black or African American
5 Participants
n=5 Participants
3 Participants
n=7 Participants
4 Participants
n=5 Participants
12 Participants
n=4 Participants
Race (NIH/OMB)
White
14 Participants
n=5 Participants
12 Participants
n=7 Participants
10 Participants
n=5 Participants
36 Participants
n=4 Participants
Race (NIH/OMB)
More than one race
1 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
5 Participants
n=4 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
2 Participants
n=4 Participants
Laceration Length (cm)
1.50 cm
n=5 Participants
1.00 cm
n=7 Participants
1.50 cm
n=5 Participants
1.50 cm
n=4 Participants
Laceration Width (cm)
0.50 cm
n=5 Participants
0.50 cm
n=7 Participants
0.50 cm
n=5 Participants
0.50 cm
n=4 Participants
Training Level of Proceduralist
Resident
7 Participants
n=5 Participants
11 Participants
n=7 Participants
10 Participants
n=5 Participants
28 Participants
n=4 Participants
Training Level of Proceduralist
Fellow
4 Participants
n=5 Participants
2 Participants
n=7 Participants
1 Participants
n=5 Participants
7 Participants
n=4 Participants
Training Level of Proceduralist
Nurse Practitioner
6 Participants
n=5 Participants
3 Participants
n=7 Participants
4 Participants
n=5 Participants
13 Participants
n=4 Participants
Training Level of Proceduralist
Attending
3 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
7 Participants
n=4 Participants

PRIMARY outcome

Timeframe: 3 months

Population: 55 subjects were enrolled in the Emergency Department but only 30 subjects sent 3 month follow-up photos of their child's scar thus only 30 scars were reviewed by the plastic surgeons.

Two blinded Plastic Surgeons will rate the cosmetic outcome of the laceration using a 0 to 100 mm Visual Analogue Scale with a score of 0 corresponding to "worst scar" and a score of 100 corresponding to "best scar"

Outcome measures

Outcome measures
Measure
Absorbable Sutures
n=12 Participants
Patients will have their laceration closed with sutures that absorb on their own and do not need to be removed. Absorbable Sutures: The patient's doctor will close the patient's laceration with absorbable sutures.
Steri-Strips
n=11 Participants
Patients will have their laceration closed with a special medical tape called "Steri-Strips." Steri-Strips: The patient's doctor will close the patient's laceration with Steri-Strips.
Dermabond
n=7 Participants
Patients will have their laceration closed with a special skin glue called "Dermabond" Dermabond: The patient's doctor will close the patient's laceration with Dermabond.
Cosmetic Outcome of Scar at 3 Months
64.00 units on a visual analog scale
Interval 51.0 to 76.0
54.00 units on a visual analog scale
Interval 35.5 to 66.75
48.50 units on a visual analog scale
Interval 29.5 to 78.75

SECONDARY outcome

Timeframe: Baseline

Parents will each be asked to score how much pain they felt the patient experienced using a 100 mm Visual Analogue Scale with a score of 0 corresponding to "No pain" and a score of 100 corresponding to "Terrible pain."

Outcome measures

Outcome measures
Measure
Absorbable Sutures
n=20 Participants
Patients will have their laceration closed with sutures that absorb on their own and do not need to be removed. Absorbable Sutures: The patient's doctor will close the patient's laceration with absorbable sutures.
Steri-Strips
n=17 Participants
Patients will have their laceration closed with a special medical tape called "Steri-Strips." Steri-Strips: The patient's doctor will close the patient's laceration with Steri-Strips.
Dermabond
n=18 Participants
Patients will have their laceration closed with a special skin glue called "Dermabond" Dermabond: The patient's doctor will close the patient's laceration with Dermabond.
Pain Experienced by Patient as Reported by Parent
17.00 units on a scale
Interval 1.5 to 51.5
22.00 units on a scale
Interval 9.0 to 28.0
11.00 units on a scale
Interval 3.0 to 24.5

SECONDARY outcome

Timeframe: Baseline to wound closure, up to 30 minutes

Parents will report their satisfaction with Emergency Department length of stay using a 100-point visual analog scale with "100" meaning completely satisfied and "0" meaning not at all satisfied

Outcome measures

Outcome measures
Measure
Absorbable Sutures
n=20 Participants
Patients will have their laceration closed with sutures that absorb on their own and do not need to be removed. Absorbable Sutures: The patient's doctor will close the patient's laceration with absorbable sutures.
Steri-Strips
n=17 Participants
Patients will have their laceration closed with a special medical tape called "Steri-Strips." Steri-Strips: The patient's doctor will close the patient's laceration with Steri-Strips.
Dermabond
n=18 Participants
Patients will have their laceration closed with a special skin glue called "Dermabond" Dermabond: The patient's doctor will close the patient's laceration with Dermabond.
Satisfaction With Time in the Emergency Department
89.50 units on a scale
Interval 45.25 to 98.5
92.00 units on a scale
Interval 83.0 to 100.0
94.00 units on a scale
Interval 71.25 to 100.0

SECONDARY outcome

Timeframe: Post-wound closure, approximately 30 minutes

Parents will be asked to rate how likely they would be to recommend the closure method used for their child using a 0 to 100 mm Visual Analogue Scale with a score of 0 corresponding to "Extremely unlikely" and a score of 100 corresponding to "Extremely likely"

Outcome measures

Outcome measures
Measure
Absorbable Sutures
n=20 Participants
Patients will have their laceration closed with sutures that absorb on their own and do not need to be removed. Absorbable Sutures: The patient's doctor will close the patient's laceration with absorbable sutures.
Steri-Strips
n=17 Participants
Patients will have their laceration closed with a special medical tape called "Steri-Strips." Steri-Strips: The patient's doctor will close the patient's laceration with Steri-Strips.
Dermabond
n=18 Participants
Patients will have their laceration closed with a special skin glue called "Dermabond" Dermabond: The patient's doctor will close the patient's laceration with Dermabond.
Likelihood That Parent Would Recommend Laceration Closure Method
99.50 units on a scale
Interval 88.0 to 100.0
99.00 units on a scale
Interval 95.0 to 100.0
99.50 units on a scale
Interval 94.5 to 100.0

SECONDARY outcome

Timeframe: 3 months

Population: 55 subject were enrolled but only 30 completed 3 month follow-up. This outcome measure was collected at 3 months.

Parents will be asked by phone at 3 months if there were any complications with their child's cut (infection, opening of the wound, etc.). Investigators will count the number of complications reported.

Outcome measures

Outcome measures
Measure
Absorbable Sutures
n=12 Participants
Patients will have their laceration closed with sutures that absorb on their own and do not need to be removed. Absorbable Sutures: The patient's doctor will close the patient's laceration with absorbable sutures.
Steri-Strips
n=11 Participants
Patients will have their laceration closed with a special medical tape called "Steri-Strips." Steri-Strips: The patient's doctor will close the patient's laceration with Steri-Strips.
Dermabond
n=7 Participants
Patients will have their laceration closed with a special skin glue called "Dermabond" Dermabond: The patient's doctor will close the patient's laceration with Dermabond.
Number of Complications of the Wound Site
0 complications
0 complications
0 complications

SECONDARY outcome

Timeframe: 3 months

Population: Only 30 parents/subjects provided 3 month follow-up photos of their scar

Parents will rate the cosmetic outcome of the laceration using a 0 to 100 mm Visual Analogue Scale with a score of 0 corresponding to "worst scar" and a score of 100 corresponding to "best scar".

Outcome measures

Outcome measures
Measure
Absorbable Sutures
n=12 Participants
Patients will have their laceration closed with sutures that absorb on their own and do not need to be removed. Absorbable Sutures: The patient's doctor will close the patient's laceration with absorbable sutures.
Steri-Strips
n=11 Participants
Patients will have their laceration closed with a special medical tape called "Steri-Strips." Steri-Strips: The patient's doctor will close the patient's laceration with Steri-Strips.
Dermabond
n=7 Participants
Patients will have their laceration closed with a special skin glue called "Dermabond" Dermabond: The patient's doctor will close the patient's laceration with Dermabond.
Parental Reported Satisfaction With the Cosmetic Appearance of the Scar
70.50 units on a scale
Interval 59.75 to 76.75
67.00 units on a scale
Interval 55.0 to 78.0
85.00 units on a scale
Interval 73.0 to 90.0

SECONDARY outcome

Timeframe: 3 months

Population: 55 subjects were enrolled but only 30 subjects submitted scar photos 3 months after closure.

Plastic Surgeons will record if a scar appears to have "train tracks" (or small dots on either side of a scar, all along the scar, usually caused by stitches) as they are rating each photo of the scar at 3 months post-closure. Surgeons will answer "yes" or "no".

Outcome measures

Outcome measures
Measure
Absorbable Sutures
n=12 Participants
Patients will have their laceration closed with sutures that absorb on their own and do not need to be removed. Absorbable Sutures: The patient's doctor will close the patient's laceration with absorbable sutures.
Steri-Strips
n=11 Participants
Patients will have their laceration closed with a special medical tape called "Steri-Strips." Steri-Strips: The patient's doctor will close the patient's laceration with Steri-Strips.
Dermabond
n=7 Participants
Patients will have their laceration closed with a special skin glue called "Dermabond" Dermabond: The patient's doctor will close the patient's laceration with Dermabond.
Presence of Train Tracks at the Scar Site
4 scars with train tracks
4 scars with train tracks
3 scars with train tracks

Adverse Events

Absorbable Sutures

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Steri-Strips

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Dermabond

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Holly Hanson

Vanderbilt University Medical Center

Phone: 615-936-7317

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place